![]() |
市場調查報告書
商品編碼
1989129
情緒食品市場預測至2034年-全球產品類型、主要成分、功能、特性、包裝、年齡層、目標受眾、通路和區域分析Mood Food Market Forecasts to 2034 - Global Analysis By Product Type, Key Ingredient, Functional Benefit, Nature, Packaging Format, Age Group, Target Group, Distribution Channel, and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球情緒食品市場規模將達到 25 億美元,並在預測期內以 12.9% 的複合年成長率成長,到 2034 年將達到 67 億美元。
情緒食品是指透過腸腦軸對心理健康、認知功能和情緒平衡有正面影響的功能性產品。這些食品和飲料含有適應原、促智劑、益生菌和植物萃取物,旨在減輕壓力、提高注意力並促進放鬆。該市場涵蓋機能飲料、點心棒、乳製品替代品和膳食補充劑,定位為尋求天然心理健康解決方案的消費者的日常消費品。
壓力和焦慮症盛行率增加
全球心理健康挑戰已達到流行病的程度,壓力相關症狀影響著各行各業數百萬人。這種普遍性促使消費者尋求預防性的營養干預措施,以在不依賴藥物的情況下維持情緒平衡。 「情緒食品」以其價格實惠、成分客觀的解決方案吸引著那些尋求自然心理健康方法的人們,這些方案可以融入日常飲食習慣。隨著人們對心理健康話題的日益關注和接受,功能性食品也進一步推動了相關產品的普及,消費者公開尋求並共用透過選擇機能性食品來管理壓力、提高專注力和穩定情緒的解決方案。
缺乏關於有效性的科學證據
許多聲稱能改善情緒的成分缺乏強力的臨床證據來支持其心理效應,這導致注重實證的消費者對其持懷疑態度。傳統使用的適應原和植物成分往往缺乏現代研究支持,而新興化合物則需要相當長的時間進行檢驗。這種科學上的空白限制了市場宣傳,也使消費者教育變得更加複雜。醫療保健專業人員可能不願意推薦缺乏可靠療效數據的產品,限制了專家建議的管道。製造商必須投入大量資金進行研發以證明其有效性,這導致研發成本增加,並延緩了有前景的成分和配方上市的時間。
透過與數位健康整合實現個人化
消費者基因組學、微生物組檢測和數位健康平台的進步,使得改善情緒的食品推薦實現了前所未有的個人化。消費者現在可以透過智慧型手機應用程式和線上評估,獲得根據其獨特的基因譜、腸道微生物組和壓力反應量身定做的產品提案。這種個人化使個人能夠體驗到符合自身特定需求的成果,從而提高對產品功效的認知,並增強消費者的參與度。食品製造商與數位健康公司之間的合作,創造了新的分銷管道和數據豐富的反饋循環,從而能夠持續改進產品,並透過客製化的健康之旅增強消費者忠誠度。
對功能性聲明的監管
全球監管機構正日益嚴格地審查食品飲料生產商關於心理益處的宣傳。衛生部門要求提供充分的科學證據,才能批准將成分與情緒改善、壓力緩解或認知功能增強聯繫起來的宣傳。這種法規環境帶來了合規風險,做出未經證實宣傳的公司可能面臨整改措施、產品查封或強制更改標籤。由於不同司法管轄區的法規各不相同,企業需要根據當地情況調整產品配方和行銷材料,這使得國際市場擴張變得更加複雜。小規模、具有創新精神的公司在法律和科學資源有限的情況下,面臨著應對複雜監管環境的獨特挑戰。
在全球隔離、不確定性和健康焦慮加劇的背景下,新冠肺炎疫情大大提升了消費者對心理健康的關注。封鎖措施促使人們尋求居家養生之道,包括有助於情緒平衡的機能性食品。供應鏈中斷最初為原料採購帶來了挑戰,但電子商務的快速發展確保了市場供應的持續暢通。疫情對心理健康的持續影響鞏固了消費者對情緒調節產品的需求。即使在急性健康問題消退之後,消費者仍然高度重視飲食與心理健康之間的關聯。
在預測期內,機能飲料細分市場預計將佔據最大的市場佔有率。
在預測期內,機能飲料預計將佔據最大的市場佔有率。這主要得益於其便利性、消費者對其形式的熟悉度以及頻繁的消費需求。即飲飲料、功能性粉末和草本茶能夠無縫融入日常生活,最大限度地減少消費者尋求心理健康益處時的行為改變。與固態食物相比,飲料中的成分吸收速度較快,因此其效果也更容易顯現。在雜貨店、便利商店和專賣店等成熟的分銷管道為消費者提供了廣泛的購買管道,而口味和配方方面的不斷創新也持續擴大了其對所有尋求便捷情緒調節解決方案的消費者群體的吸引力。
預計在預測期內,CBD和大麻萃取物細分市場將實現最高的複合年成長率。
在預測期內,CBD和工業大麻萃取物細分市場預計將呈現最高的成長率,這主要得益於合法化進程的推進以及消費者對天然抗焦慮產品日益成長的需求。這些化合物與人體的內源性大麻素系統相互作用,可能有助於促進平靜和情緒平衡,且不產生精神活性作用。隨著研究顯示它們對壓力、睡眠和情緒調節的正面影響,社會對其的接受度也迅速提高。飲料、零食和膳食補充劑等產品的創新正在加速市場滲透,而名人代言和社交媒體的曝光則將這些成分介紹給全球範圍內日益成長的、接受度更高的消費者群體。
在整個預測期內,北美預計將保持最大的市場佔有率,這得益於其成熟的健康文化、較高的可支配收入以及對機能性食品潮流的早期接受。該地區的消費者渴望嘗試能夠改善情緒的成分,並且願意為提升心理健康的益處支付更高的價格。由於涵蓋天然食品零售商和主流雜貨店通路的廣泛分銷網路,消費者可以輕鬆購買到相關產品。在具有影響力的健康媒體和充滿活力的Start-Ups系統不斷推動創新的同時,美國和加拿大針對CBD和工業大麻萃取物的法規結構正在為成分實驗創造一個系統化的市場環境。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於當地對有助於心理健康的傳統藥材成分的深厚文化親和性。印度的阿育吠陀醫學原理以及全部區域的傳統中醫實踐,長期以來都將具有情緒穩定作用的草藥和植物成分納入日常飲食,從而贏得了消費者的廣泛認可。快速的都市化、可支配收入的成長以及日益加劇的工作壓力,正在擴大尋求便捷心理健康解決方案的潛在消費群體。國際機能性食品品牌透過策略合作進入這些市場,而當地製造商則開發針對本地情況的配方,這些合作正在加速全部區域相關產品的接受度。
According to Stratistics MRC, the Global Mood Food Market is accounted for $2.5 billion in 2026 and is expected to reach $6.7 billion by 2034 growing at a CAGR of 12.9% during the forecast period. Mood foods are functional products formulated with ingredients that positively influence mental wellbeing, cognitive function, and emotional balance through the gut-brain axis. These foods and beverages incorporate adaptogens, nootropics, probiotics, and botanical extracts designed to reduce stress, enhance focus, and promote relaxation. The market spans functional beverages, snack bars, dairy alternatives, and dietary supplements positioned as everyday consumables for consumers seeking natural mental wellness solutions.
Rising prevalence of stress and anxiety disorders
Global mental health challenges have reached epidemic proportions, with stress-related conditions affecting millions across all demographics. This widespread prevalence drives consumers toward proactive nutritional interventions that support emotional balance without pharmaceutical intervention. Mood foods offer accessible, stigma-free solutions integrated into daily eating routines, appealing to individuals seeking natural approaches to mental wellness. The normalization of conversations around mental health further encourages product trial, as consumers openly seek and share solutions for stress management, focus enhancement, and mood stabilization through functional food choices.
Limited scientific validation of efficacy
Many mood-enhancing ingredients lack robust clinical evidence supporting their psychological benefits, creating skepticism among evidence-focused consumers. Adaptogens and botanicals with traditional use histories often have limited modern research, while emerging compounds face lengthy validation timelines. This scientific gap restricts marketing claims and complicates consumer education efforts. Healthcare professionals may hesitate to recommend products without strong efficacy data, limiting professional endorsement channels. Manufacturers must invest substantially in research to substantiate benefits, increasing development costs and delaying market entry for potentially promising ingredients and formulations.
Personalization through digital health integration
Advances in consumer genomics, microbiome testing, and digital health platforms enable unprecedented personalization of mood food recommendations. Consumers can now receive product suggestions tailored to their unique genetic profiles, gut compositions, and stress responses through smartphone applications and online assessments. This personalization enhances perceived efficacy and consumer engagement, as individuals experience results aligned with their specific needs. Partnerships between food manufacturers and digital health companies create new distribution channels and data-rich feedback loops, enabling continuous product refinement and strengthening consumer loyalty through customized wellness journeys.
Regulatory scrutiny of functional claims
Regulatory authorities worldwide increasingly scrutinize psychological benefit claims made by food and beverage manufacturers. Health agencies require substantial scientific evidence before permitting statements linking ingredients to mood improvement, stress reduction, or cognitive enhancement. This regulatory environment creates compliance risks, with companies facing enforcement actions, product seizures, or mandatory label changes for unsupported claims. Evolving regulations across jurisdictions complicate international market expansion, as formulations and marketing materials require region-specific adaptations. Small innovators face particular challenges navigating complex regulatory landscapes with limited legal and scientific resources.
The COVID-19 pandemic dramatically elevated consumer focus on mental wellness as isolation, uncertainty, and health anxieties intensified globally. Lockdowns prompted exploration of at-home wellness routines, including functional foods supporting emotional balance. Supply chain disruptions initially challenged ingredient sourcing, but accelerated e-commerce adoption enabled continued market access. The pandemic's enduring mental health legacy established sustained demand for mood-supporting products, with consumers maintaining heightened awareness of the connection between diet and psychological wellbeing long after acute health concerns receded.
The Functional Beverages segment is expected to be the largest during the forecast period
The Functional Beverages segment is expected to account for the largest market share during the forecast period, driven by convenience, rapid format familiarity, and frequent consumption occasions. Ready-to-drink beverages, functional powders, and herbal infusions integrate seamlessly into daily routines, requiring minimal behavioral change from consumers seeking mental wellness benefits. Beverages offer faster ingredient absorption compared to solid foods, enhancing perceived efficacy. Established distribution channels across grocery, convenience, and specialty retailers provide broad consumer access, while innovation in flavors and formulations continuously expands appeal across demographics seeking accessible mood support solutions.
The CBD & Hemp Extracts segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the CBD & Hemp Extracts segment is predicted to witness the highest growth rate, fueled by expanding legalization and mounting consumer interest in natural anxiety relief. These compounds interact with the body's endocannabinoid system, potentially promoting calm and emotional balance without psychoactive effects. Mainstream acceptance has grown rapidly as research suggests benefits for stress, sleep, and mood regulation. Product innovation across beverages, snacks, and supplements accelerates market penetration, while celebrity endorsements and social media exposure introduce these ingredients to increasingly receptive consumer demographics worldwide.
During the forecast period, the North America region is expected to hold the largest market share, supported by sophisticated wellness culture, high disposable incomes, and early adoption of functional food trends. The region's consumers demonstrate strong willingness to experiment with mood-enhancing ingredients and pay premiums for mental wellness benefits. Extensive distribution networks across natural food retailers and mainstream grocery channels provide broad consumer access. Influential wellness media and vibrant startup ecosystems continuously introduce innovation, while regulatory frameworks for CBD and hemp extracts in the United States and Canada create structured market environments for ingredient experimentation.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by deep cultural familiarity with traditional medicine ingredients supporting mental wellness. Ayurvedic principles in India and Traditional Chinese Medicine practices across the region have long incorporated mood-balancing herbs and botanicals into daily consumption, creating inherent consumer acceptance. Rapid urbanization, rising disposable incomes, and escalating work-related stress expand the addressable consumer base seeking accessible mental wellness solutions. International functional food brands entering these markets through strategic partnerships, combined with local manufacturers developing regionally relevant formulations, accelerate adoption across this vast region.
Key players in the market
Some of the key players in Mood Food Market include Nestle S.A., Unilever PLC, PepsiCo, Inc., The Coca-Cola Company, Danone S.A., Mondelez International, Inc., General Mills, Inc., Kellogg Company, Yakult Honsha Co., Ltd., Yakult Danone India Pvt. Ltd., Hain Celestial Group, Inc., SunOpta Inc., Nature's Path Foods, Oatly Group AB, and Laird Superfood, Inc.
In February 2026, Yakult announced the European launch of Yakult Vitals, a new dairy-free fermented soy drink fortified with Vitamin D and minerals, targeting the vegan functional beverage market.
In February 2026, Nestle announced the formal engagement process to find potential partners for its Waters & Premium Beverages business, with plans for full deconsolidation by 2027 to focus on high-growth areas like Coffee and Medical Nutrition.
In December 2025, Unilever completed the demerger of its Ice Cream business, listing The Magnum Ice Cream Company N.V. as a standalone entity to allow Unilever to focus on high-margin functional and personal care markets.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.